Argent Trust »

Halozyme Therapeutics shares owned by Argent Trust

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Argent Trust from 13F filings

Historical chart of Argent Trust investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Argent Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Argent Trust

Quarter filed Position value Share count Share price at filing
2023-12-31 $61k 70k 0.86
2023-09-30 $59k 70k 0.84
2023-06-30 $58k 70k 0.83

More positions owned by Argent Trust

Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Jpmorgan Chase & Co Common Stock (JPM)
SPDR S&P 500 Etf-equity (SPY)
Alphabet Common Stock (GOOGL)
Home Depot Common Stock (HD)
Ishares Etf-equity (IVV)
Abbvie Common Stock (ABBV)
Amazon Common Stock (AMZN)
Johnson & Johnson Common Stock (JNJ)
Chevron Corp Common Stock (CVX)
Walmart Common Stock (WMT)
Visa Common Stock (V)
Alphabet Common Stock (GOOG)
Coca-cola Common Stock (KO)

View all positions for Argent Trust

Top funds holding Halozyme Therapeutics

Wellesley Investment Advisors
Davidson Kempner Capital Management
Lazard Asset Management
Citigroup
Aviva
Citadel Advisors
D. E. Shaw & Co
Wells Fargo & Company
Readystate Asset Management
Tenor Capital Management
Wolverine Asset Management
Victory Capital Management
Jpmorgan Chase & Co
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Shenkman Capital Management

View all funds holding Halozyme Therapeutics